Press Releases

01.26.17
OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results
12.19.16
OpGen Supports Passage of Landmark 21st Century Cures Act to Expedite Development of Solutions for Bacterial Infections
12.16.16
OpGen Provides ATM Program Update
11.14.16
OpGen Collaborates With Merck to Develop Novel Rapid Diagnostics and Informatics Tools to Combat Antibiotic Resistance
10.27.16
Large Integrated Health Outcomes Study Reveals Shifting Epidemiology In Drug Resistant Organisms
10.26.16
OpGen’s Infectious Disease Portfolio Highlighted at IDWeek 2016
10.24.16
OpGen Reports 2016 Third Quarter Financial Results and Provides Business Update
10.19.16
OpGen Announces Date of Third Quarter 2016 Financial Results Conference Call
09.08.16
OpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance Congress
09.07.16
OpGen to Present at the Rodman & Renshaw 18th Annual Global Investment Conference